Dr. Kenneth David Chavin, MD, PhD

Dr. Chavin practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Chavin's NPI, 1801901731, was assigned on August 20, 2006. Dr. Chavin graduated from Temple University School of Medicine in 1987. Dr. Chavin holds Pennsylvania license MD043970E.

Dr. Chavin's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Chavin's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Chavin is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Chavin to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chavin practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Chavin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Chavin's licenses on file in 2 states: Pennsylvania and Ohio.

CMS data shows 106 Medicare services from Dr. Chavin across 5 procedure codes in 2024, for 48 Medicare patients. Medicare paid $31,526 for them.

CMS counts 48 Medicare patients who saw Dr. Chavin in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 8.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chavin's median patient age at 57, with 37% women.

In 2022, Dr. Chavin wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $48 in total drug cost. In 2021, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Chavin for performance year 2024, reported as part of a group. Dr. Chavin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 120 papers to Dr. Chavin, published from 2004 to 2024. 2016 was the busiest year, with 10. The most frequent topics are Kidney Transplantation, Liver Transplantation and Graft Rejection. Dr. Chavin has published most often in Clin Transplant. Dr. Chavin's most frequent co-authors are Prabhakar Baliga, MD, John William McGillicuddy, MD and Charles Fitzgerald Bratton, MD.

Dmand AI links Dr. Chavin to 3 clinical trials. Conditions studied include Carcinoma, Hepatocellular, Hepatitis C and Fibrosis.

CMS Open Payments shows 44 general payments to Dr. Chavin from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Sanofi and Genzyme US Companies paid the most, $6,893. It also lists 2 research payments totaling $20,000 from 2016 to 2019.

Dr. Chavin graduated from Temple University School of Medicine in 1987.